The gold in the syrup can help revive the production of molecules necessary for proper brain function and help treat neurodegenerative diseases like Parkinson’s or Charcot.
From Egyptian healers to alchemists to modern doctors, everyone has said that gold can heal. And it has always been proven wrong. If gold is recognized as a mineral with interesting properties, then The golden cure For example, those introduced in the 20th century to treat tuberculosis or rheumatoid arthritis (chronic inflammation of the joints) have proven ineffective. But science has progressed, and now, gold nanocrystal therapy is showing encouraging results on certain diseases, such as Parkinson’s or Charcot’s disease.
A (truly) magical potion
Thus, as indicated in a press release, phase 2 clinical trials using orally administered gold nanocrystals for the treatment of multiple sclerosis and Parkinson’s disease have been made possible. Restore good levels of critical molecules Connected with the energetic activity of the brain, but when this organ is affected, it is deficient Neurodegenerative disease. In summary, when you’re affected by the end stages of these diseases, it’s the brain that takes the hit: the latter requires Fuel which the body is incapable of producing.
But based on treatment Small gold crystals, which we drink through drinks, can change the situation and increase the production of this fuel. In a trial conducted by American researchers from the University of Texas, 13 patients with Parkinson’s disease and 11 patients affected by multiple sclerosis consumed it. 120 ml of this magic potion daily for three months. By the end of the first month, patients suffering from Parkinson’s disease saw concrete improvements in their motor skills, which was confirmed by various tests assessing different parameters (chewing/swallowing, writing, walking, speaking, manipulation). , trembling).
“we are Cautiously optimistic For our faculty has Prevent or reverse Certain neurological disabilities with this strategy”said neurologist Peter Sgugna, one of the co-authors of the study published in the journal. Journal of Nanobiotechnology. Research on larger numbers of patients is needed, but these results still offer hope for patients and future patients. In France, Parkinson’s disease affects 200,000 people, and multiple sclerosis affects more than 115,000; These figures will continue to increase as the population ages.
You may also be interested in:
⋙ Radithor, a radioactive energy drink that melts the skulls of those who drink it
⋙ Maggots, leeches… this medieval treatment could be the medicine of tomorrow
⋙ Eating mummy cures diseases? Rumors had long circulated in Europe
Treatment of Parkinson’s disease (T) medication
Source link
